Paper II — 2025 March (Supplementary (SAY)) (2019 Scheme) — Qxviii

Paper II

2025 March (Supplementary (SAY)) (2019 Scheme) · 100 marks · 180 min

Question

All of the following are prognostic parameters in the evaluation of Breast Carcinoma EXCEPT

• a) Tumour grade
• c) Hormone Receptor status
• b) Axillary Lymphnode status
• d) Parity status

Qxviii1 marksMCQs★✓

Answer

Correct answer: d) Parity status

Parity status (number of pregnancies/childbirths) is a risk factor influencing the likelihood of developing breast carcinoma (nulliparity increases risk), but it is not a prognostic parameter used to evaluate the outcome of an already-diagnosed cancer. Tumour grade, axillary lymph node status, and hormone receptor (ER/PR) status are all genuine, established prognostic (and in the case of hormone receptors, also predictive) parameters used in breast cancer evaluation.

Related Concepts

1. 1Acute Leukaemia

Other Years Asked

1. 1Laboratory diagnosis of acute promyelocytic leukemia.2022 February (2019 Scheme)Short Answer · 4 marks
2. 2Peripheral blood picture in acute myeloid leukemia2024 June (Supplementary) (2019 Scheme)Short Answer · 4 marks
3. 3Differential diagnosis of pancytopenia.2022 February (2019 Scheme)Short Answer · 4 marks
4. 4What is Ki 67.2022 July (Supplementary) (2019 Scheme)1 mark
5. 5All are true statement about HER2 positive invasive carcinoma breast EXCEPT2025 March (Supplementary (SAY)) (2019 Scheme)MCQ · 1 mark
6. 6All are true about carcinoma endometrium EXCEPT2025 March (Supplementary (SAY)) (2019 Scheme)MCQ · 1 mark
7. 7(A) Prophylactic colectomy is to be done in all patients with Familial Adenomatous Polyposis (FAP) (R) Minimum 100 polyps are necessary for the diagnosis of FAP2025 March (Supplementary (SAY)) (2019 Scheme)MCQ · 1 mark
8. 8Name ONE cancer that commonly spreads by hemotagenous route2024 June (Supplementary) (2019 Scheme)1 mark
9. 9Stain used to demonstrate myeloblasts in acute leukemia is __________________.2022 July (Supplementary) (2019 Scheme)1 mark
10. 10Which one of the following investigation is diagnostic2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (Case) · 1 mark